VYONDYS 53 FDA approval date

The FDA approved VYONDYS 53 on 12 Dec 2019.

FDA approval date
12 Dec 2019

Drug identity has not yet been verified against registry records

Also recorded as GOLODIRSEN

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-12-12DayVYONDYS 53FDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA211970", "applicant_as_listed_by_fda": "SAREPTA THERAPS INC", "brand_names": ["VYONDYS 53"], "active_ingredients": ["GOLODIRSEN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20191212", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026